Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures

Neurology

Volumn 67, Issue 4, 2006, Pages 679-682

  Donati, F ^a   Gobbi, G ^b   Campistol, J ^c   Rapatz, G ^d   Daehler, M ^d   Sturm, Y ^d   Aldenkamp, A P ^e,f  

^a Neurologische Universitatsklinik Bern   (Switzerland)

^b MAGGIORE HOSPITAL   (Italy)

^c HOSPITAL SANT JOAN DE DÉU   (Spain)

^d NOVARTIS PHARMA AG   (Switzerland)

^e EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^f MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; OXCARBAZEPINE; VALPROIC ACID;

ADOLESCENT; ADULT DISEASE; ALOPECIA; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG ERUPTION; DRUG INDUCED HEADACHE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; FOCAL EPILEPSY; HUMAN; INCREASED APPETITE; MALE; MULTICENTER STUDY; NEUROTOXICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; COGNITION; COGNITION DISORDERS; DRUG COMBINATIONS; EPILEPSIES, PARTIAL; EUROPE; FEMALE; HUMANS; MALE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 33747661652     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000230138.46508.5b     Document Type: Article

References (10)

1. Motamedi G, Meador K. Epilepsy and cognition. Epilepsy Behav 2003;4(suppl 2):S25-S38.
2. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 1995;36(suppl 2):S46-S65.
3. Motamedi GK, Meador KJ. Antiepileptic drugs and memory. Epilepsy Behav 2004;5:435-439.
4. Aldenkamp AP, De Krom M, Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003;44(suppl 4):21-29.
5. Aldenkamp AP, Alpherts WCJ, Blennow G, et al. Withdrawal of antiepileptic medication - effects on cognitive function in children - the results of the multicentre 'Holmfrid' study. Neurology 1993;43:41-51.
6. Beydoun A. Safety and efficacy of oxcarbazepine: results of randomized, double-blind trials. Pharmacotherapy 2000;20:152S-158S.
7. Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. Neurology 2000;54:2237-2244.
8. Lezak M. Neuropsychological Assessment, 3rd ed. New York: Oxford University Press, 1995.
9. Dam M, Ekberg R, Løyning Y, Waltimo O, Jakobsen K, The Scandinavian Oxcarbazepine Study Group. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989;3:70-76.
10. Van Parys JA, Meinardi H. Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis. Epilepsy Res 1994;19:79-85.